Pembrolizumab + Idelalisib for Lung Cancer Study
Clinical trial NCT03257722 · TERMINATED
Trial details
- NCT number
- NCT03257722
- Sponsor
- Asha Nayak
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2020-08-15
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.